Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872777 · ClinicalTrials.gov registry record · NA
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
A NA study of Nonalcoholic Steatohepatitis, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04872777: Completed NA study of Nonalcoholic Steatohepatitis, sponsored by Milton S. Hershey Medical Center.
NCT04872777 is a NA study of Nonalcoholic Steatohepatitis that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 40 participants, below the 701-participant average among 30 other Nonalcoholic Steatohepatitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04872777, a NA study of Nonalcoholic Steatohepatitis, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a clear unmet clinical need for effective lifestyle intervention in patients with nonalcoholic steatohepatitis (NASH). Patients have self-identified multiple barriers to effective lifestyle intervention can be removed with a mobile health (mHealth) platform. This study will be a proof of concept study to evaluate weight loss efficacy of Noom Healthy Weight (HW), a mHealth lifestyle intervention, in patients with NASH.
Primary Outcome
Change in self-measured body weight
Conditions Studied
Interventions
- BEHAVIORAL Noom Healthy Weight
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-08 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
What the finished NCT04872777 record still lists
NCT04872777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 701-participant average among 30 other Nonalcoholic Steatohepatitis trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 1 intervention - of which Noom Healthy Weight is the first listed.
NCT04872777 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04872777 about?
NCT04872777 is a clinical study titled "Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH". There is a clear unmet clinical need for effective lifestyle intervention in patients with nonalcoholic steatohepatitis (NASH). Patients have self-identified multiple barriers to effective lifestyle intervention can be removed with a mobile health (mHealth) platform. This study will be a proof of c...
What is the current status of trial NCT04872777?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-06-08. Estimated completion is 2022-02-10.
What conditions does trial NCT04872777 study?
This clinical trial studies the following conditions: Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT04872777?
The interventions under investigation include: Noom Healthy Weight (BEHAVIORAL).
Who is sponsoring clinical trial NCT04872777?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04872777 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonalcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04872777's enrollment target sits among peer trials
40 27th of 30 higher than 4 of 30 other Nonalcoholic Steatohepatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nonalcoholic Steatohepatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Metabolic Pathology of Pediatric NAFLD
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
COMPLETED · NA
-
Feasibility of VIIT in Adults With NASH
COMPLETED · NA
-
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI